Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | KIFC1 | Q9BW19 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.41 |
| ▸ | PLK1 | P53350 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL326777 | 0.82 | L3MBTL1 (0.68) | L3MBTL1CHRNA7TP53MAPTNPC1 | |
| SCHEMBL30454185 | 0.82 | L3MBTL1 (0.68) | L3MBTL1CHRNA7TP53MAPTNPC1 | |
| SCHEMBL13130238 | 0.79 | L3MBTL1 (1.00) | L3MBTL1CHRNA7TP53MAPTNPC1 | |
| SCHEMBL16579433 | 0.79 | TP53 (0.51) | L3MBTL1TP53MAPTNPC1RAB9A | |
| SCHEMBL16572041 | 0.78 | PPARA (0.50) | L3MBTL1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15233029 | 0.78 | PPARA (0.50) | L3MBTL1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30497107 | 0.78 | L3MBTL1 (0.70) | L3MBTL1TP53MAPTNPC1RAB9A | |
| SCHEMBL225165 | 0.78 | L3MBTL1 (0.70) | L3MBTL1TP53MAPTNPC1RAB9A | |
| SCHEMBL1020649 | 0.77 | L3MBTL1 (0.68) | L3MBTL1CHRNA7TP53MAPTNPC1 | |
| SCHEMBL13167067 | 0.76 | SIRT2 (0.51) | L3MBTL1MAPTNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9481658-B2 | Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound | FUJIFILM CORPORATION (JP) | 2016-11-01 | — | — | US | disclosed |
| US-20150080582-A1 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND | FUJIFILM CORPORATION (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8524334-B2 | Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound | FUJIFILM CORPORATION (JP) | 2013-09-03 | — | — | US | disclosed |
| US-20100239788-A1 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND | FUJIFILM CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080582-A1 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND | PYM1, CCND2, CCNB2 | L3MBTL1 101/4885CHRNA7 3866/4885TP53 2976/4885 |
| US-20100239788-A1 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND | PYM1, CCND2, CCNB2 | L3MBTL1 87/4885CHRNA7 3879/4885TP53 2833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.